These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 21407136)

  • 1. Risk of venous thromboembolism by route of administration of estrogen.
    Lobo RA
    Menopause; 2011 May; 18(5):469-70. PubMed ID: 21407136
    [No Abstract]   [Full Text] [Related]  

  • 2. Hormone therapy and recurrence of venous thromboembolism among postmenopausal women.
    Olié V; Plu-Bureau G; Conard J; Horellou MH; Canonico M; Scarabin PY
    Menopause; 2011 May; 18(5):488-93. PubMed ID: 21178641
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hormone therapy and risk of venous thromboembolism among postmenopausal women.
    Canonico M; Scarabin PY
    Climacteric; 2009; 12 Suppl 1():76-80. PubMed ID: 19811247
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transdermal and vaginal estradiol for the treatment of menopausal symptoms: the nuts and bolts.
    Kaunitz AM
    Menopause; 2012 Jun; 19(6):602-3. PubMed ID: 22549171
    [No Abstract]   [Full Text] [Related]  

  • 5. Further evidence for promoting transdermal estrogens in the management of postmenopausal symptoms.
    Canonico M; Scarabin PY
    Menopause; 2011 Oct; 18(10):1038-9. PubMed ID: 21946050
    [No Abstract]   [Full Text] [Related]  

  • 6. ACOG committee opinion no. 556: Postmenopausal estrogen therapy: route of administration and risk of venous thromboembolism.
    Obstet Gynecol; 2013 Apr; 121(4):887-890. PubMed ID: 23635705
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased thrombin generation among postmenopausal women using hormone therapy: importance of the route of estrogen administration and progestogens.
    Scarabin PY; Hemker HC; Clément C; Soisson V; Alhenc-Gelas M
    Menopause; 2011 Aug; 18(8):873-9. PubMed ID: 21487317
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hormone therapy and venous thromboembolism among postmenopausal women.
    Scarabin PY
    Front Horm Res; 2014; 43():21-32. PubMed ID: 24943295
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hormones and venous thromboembolism among postmenopausal women.
    Scarabin PY
    Climacteric; 2014 Dec; 17 Suppl 2():34-7. PubMed ID: 25223916
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Type of hormone replacement therapy and risk of venous thromboembolism.
    Roberts H
    BMJ; 2008 May; 336(7655):1203-4. PubMed ID: 18495630
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Hormone replacement therapy and venous thromboembolism].
    Pavičić Baldani D; Skrgatić L; Simunić V; Elvedi Gasparović V; Geršak B
    Lijec Vjesn; 2015; 137(1-2):34-40. PubMed ID: 25906547
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patch instead of pill: a safer menopausal estrogen?
    Cushman M
    Arterioscler Thromb Vasc Biol; 2010 Feb; 30(2):136-7. PubMed ID: 20089948
    [No Abstract]   [Full Text] [Related]  

  • 13. Hormone therapy and hemostasis among postmenopausal women: a review.
    Canonico M
    Menopause; 2014 Jul; 21(7):753-62. PubMed ID: 24937030
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Postmenopausal hormone therapy and risk of idiopathic venous thromboembolism: results from the E3N cohort study.
    Canonico M; Fournier A; Carcaillon L; Olié V; Plu-Bureau G; Oger E; Mesrine S; Boutron-Ruault MC; Clavel-Chapelon F; Scarabin PY
    Arterioscler Thromb Vasc Biol; 2010 Feb; 30(2):340-5. PubMed ID: 19834106
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synergism between non-O blood group and oral estrogen in the risk of venous thromboembolism among postmenopausal women: The ESTHER study.
    Canonico M; Olié V; Carcaillon L; Tubert-Bitter P; Scarabin PY;
    Thromb Haemost; 2008 Jan; 99(1):246-8. PubMed ID: 18217166
    [No Abstract]   [Full Text] [Related]  

  • 16. Effect of NFE2L2 genetic polymorphism on the association between oral estrogen therapy and the risk of venous thromboembolism in postmenopausal women.
    Bouligand J; Cabaret O; Canonico M; Verstuyft C; Dubert L; Becquemont L; Guiochon-Mantel A; Scarabin PY;
    Clin Pharmacol Ther; 2011 Jan; 89(1):60-4. PubMed ID: 21107315
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Hormone therapy and risk for venous thromboembolism in postmenopausal women].
    Lacut K; Oger E
    Rev Prat; 2005 Feb; 55(4):389-92. PubMed ID: 15828617
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Letter by Micheletti and Chevallier regarding article, "Hormone therapy and venous thromboembolism among postmenopausal women: impact of the route of estrogen administration and progestogens: the ESTHER Study".
    Micheletti MC; Chevallier T
    Circulation; 2007 Sep; 116(13):e362; author reply e363. PubMed ID: 17893283
    [No Abstract]   [Full Text] [Related]  

  • 19. Genetic influence of hormone-replacement therapy on venous thromboembolism.
    Sumino H; Ichikawa S; Kumakura H; Takayama Y; Kurabayashi M
    Lancet; 2003 Oct; 362(9391):1242. PubMed ID: 14568759
    [No Abstract]   [Full Text] [Related]  

  • 20. EMAS position statement: managing obese postmenopausal women.
    Lambrinoudaki I; Brincat M; Erel CT; Gambacciani M; Moen MH; Schenck-Gustafsson K; Tremollieres F; Vujovic S; Rees M; Rozenberg S
    Maturitas; 2010 Jul; 66(3):323-6. PubMed ID: 20434858
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.